GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting08-12-2021
08-12-2021
Granules India Ltd - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting17-11-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Analyst/Investor Meeting15-11-2021
Earnings Call for Q2FY22 of Granules India
Conference Call with Granules India Ltd. Management and Analysts on Q2FY22 Performance and Outlook. Listen to the full earnings transcript.13-11-2021
GRANULES INDIA LTD.-$ - 532482 - Board declares Second Interim Dividend
Granules India Ltd has informed BSE that the Board of Directors of the Company at its meeting held on November 12, 2021, inter alia, has declared second interim dividend of 25 paise per share of face value of Re. 1/- each representing 25% of paid-up capital for the financial year 2021-22.12-11-2021
GRANULES INDIA LTD.-$ - 532482 - Fixed Record Date 25Th November,2021 For Payment Of Second Interim Dividend For FY22.
Fixed Record Date 25th November,2021 for payment of Second Interim Dividend for FY22.12-11-2021
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Investor Presentation
Presentation to the Analysts/Investors12-11-2021
GRANULES INDIA LTD.-$ - 532482 - Board Meeting Outcome for Outcome Of The Board Meeting Dated 12Th November 2021.
Outcome of the Board meeting dated 12th November 2021.12-11-2021
Q2FY22 Quarterly Result Announced for Granules India Ltd.
Highlights: Granules India reports Income from operations at INR 888 Cr up 4% YoY EBITDA at INR 151 Cr, EBITDA Margin at 17% PAT at INR 81 Cr, down 51% YoY Granules Q2 business was unfavourably impacted due to difficulties in procuring Raw materials, mainly from China due to Chinese dual energy policy and increased procurement prices for almost all items due to interruptions in supply of materials and increased logistics costs arising out of vessel shortage and port congestion in various part of the world Q2FY22 revenues at INR 888 Crs, growth of 4% YoY. EBITDA stood at INR 151 Crs, down by 41% YoY. EBITDA margins stood at 17% compared to 30%. PAT at INR 81 Crs, down by 51% Gross margin % drop from 57.9% to 50.9% was on account of reduction in margins of all major products especially Paracetamol due to increase in KSM prices and increased logistics cost. Price pressure in USA has also resulted in marginal drop in Gross margin for Core products. The entire loss of Gross margin for the current quarter was mainly absorbed by Granules. We expect to pass on some of the increases to our customers from Q3FY22 onwards. Pharmaceutical Formulation Intermediates (PFI) segment grew 10% YoY, Finished Dosage (FD) grew 18% YoY and, Active Pharmaceutical Ingredients (API) segment down by 25% YoY mainly due to Paracetamol KSM supply disruption. During the quarter: Revenue share from other molecules has increased to 19% and Revenue share of FD has increased to 57% consistent with our strategy We filed one ANDA, one European Dossier, one US DMF and one CEP. R&D; expenses has significantly gone up in line with our accelerated R&D; strategy. The Board of Directors has declared its second interim dividend of 25 paise per equity share of INR 1/- each. Commenting on the results, Dr. Krishna Prasad Chigurupati, Chairman & Managing Director of Granules India Limited said, “The last quarter was one of the most challenging quarters that we have witnessed in the recent past. We were unable to pass on our cost increases to our customers. Based on ongoing discussions with customers, we are confident of passing on our price increases substantially from Q3FY22 onwards. We expect that our gross margins will see a recovery and we believe that our performance for the rest of the fiscal will be substantially better. We have been taking all necessary measures to de-risk ourselves from supply chain disruptions and expect to see these efforts bear fruits next fiscal onwards. Due to the current volatile and uncertain environment, we believe that we will not be able to meet our guidance, and it will not be prudent on our part to give any future guidance until the situation becomes stable. All our projects and plans are on track, and I am very confident that the current fiscal will be a one off and not affect our long-term growth strategy and aspirations.” Result PDF12-11-2021
Granules India Ltd - 532482 - Un-Audited Financial Results For The Quarter And Half-Year Ended September 30, 2021
Un-audited Financial Results for the quarter and Half-year ended September 30, 202112-11-2021